Pioneering studies have demonstrated the potential of cancer chronotherapy as a translational field, highlighting the relevance of the circadian clock in central cancer processes such as tumor initiation, progression52, invasion53, and treatment-related side effects54. The gene discussed is CLOCK; the disease is cancer.